Engineers Gate Manager
EWTX icon

Engineers Gate Manager’s Edgewise Therapeutics EWTX Stock Holding History

Engineers Gate Manager’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
+6,670
New +$230K ﹤0.01% 1837
2025
Q3 		– Sell
-34,909
Closed -$458K – 2273
2025
Q2 		$458K Sell
34,909
-1,449
-4% -$20.9K 0.01% 1521
2025
Q1 		$800K Buy
+36,358
New +$954K 0.01% 1191

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Engineers Gate Manager's EWTX Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 6,670 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #1837 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in EWTX as recently as Q2 2025.

Engineers Gate Manager first reported a position in EWTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $800K in Q1 2025. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Engineers Gate Manager held 6,670 shares of Edgewise Therapeutics worth $271K as of Q2 2026.
  • Edgewise Therapeutics was a new Engineers Gate Manager position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1837 holding.
  • Engineers Gate Manager first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Engineers Gate Manager's Edgewise Therapeutics position peaked at $800K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.